Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients

Journal of the American Society of Nephrology

Volumn 25, Issue 6, 2014, Pages 1303-1312

  Van Den Berg, Else ^a,b   Pasch, Andreas ^c   Westendorp, Welmoet H ^b   Navis, Gerjan ^b   Brink, Elizabeth J ^a   Gans, Reinold O B ^b   Van Goor, Harry ^b   Bakker, Stephan J L ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; HYDROGEN SULFIDE; SULFUR AMINO ACID; SULFUR DERIVATIVE; THIOSULFATE; SULFATE;

ACIDITY; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HOMEOSTASIS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLITE; MIDDLE AGED; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; AGED; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; KAPLAN MEIER METHOD; KIDNEY; METABOLISM; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK FACTOR; URINE;

ADULT; AGED; AMINO ACIDS, SULFUR; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS; SULFATES; THIOSULFATES;

EID: 84906089359     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013050497     Document Type: Article

References (44)

1. Aakhus S,Dahl K,Widerøe TE:Cardiovascularmorbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 14: 648-654, 1999
2. Kreis HA, Ponticelli C: Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors. Transplantation 71[Suppl]: SS5-SS9, 2001
3. Lentine KL, Schnitzler MA, Abbott KC, Li L, Burroughs TE, Irish W, Brennan DC: De novo congestive heart failure after kidney transplantation: A common condition with poor prognostic implications.Am J Kidney Dis 46: 720-733, 2005
4. Yakupoglu HY, Corsenca A, Wahl P, Wüthrich RP, Ambühl PM: Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft. Transplantation 84: 1151-1157, 2007
5. van den Berg E, Geleijnse JM, Brink EJ, van Baak MA, Homan van der Heide JJ, Gans RO, Navis G, Bakker SJ: Sodium intake and blood pressure in renal transplant recipients. Nephrol Dial Transplant 27: 3352-3359, 2012
6. van den Berg E, Engberink MF, Brink EJ, van Baak MA, Joosten MM, Gans RO, Navis G, Bakker SJ: Dietary acid load and metabolic acidosis in renal transplant recipients. Clin J Am Soc Nephrol 7: 1811-1818, 2012
7. Szabó C, Papapetropoulos A: Hydrogen sulphide and angiogenesis: Mechanisms and applications. Br J Pharmacol 164: 853-865, 2011
8. Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Russo G, Caliendo G, Santagada V, Cirino G, Wallace JL, Fiorucci S: 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in amodel of postinflammatory hypersensitivity. J Pharmacol Exp Ther 319: 447-458, 2006
9. Chen CQ, Xin H, Zhu YZ: Hydrogen sulfide: Third gaseous transmitter, but with great pharmacological potential. Acta Pharmacol Sin 28: 1709-1716, 2007
10. Blackstone E, Morrison M, Roth MB: H2S induces a suspended animationlike state in mice. Science 308: 518, 2005
11. Blackstone E, Roth MB: Suspended animation-like state protects mice from lethal hypoxia. Shock 27: 370-372, 2007
12. Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung SM, Bhunia AK, Barodka VM, Gazi FK, Barrow RK,Wang R, Amzel LM, Berkowitz DE, Snyder SH: Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 109: 1259-1268, 2011
13. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, CirinoG,Wallace JL: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20: 2118-2120, 2006
14. Bos EM, Leuvenink HG, Snijder PM, Kloosterhuis NJ, Hillebrands JL, Leemans JC, Florquin S, van Goor H: Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 20: 1901-1905, 2009
15. Bos EM, Snijder PM, Jekel H, Weij M, Leemans JC, van Dijk MC, Hillebrands JL, Lisman T, van Goor H, Leuvenink HG: Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury. Transpl Int 25: 897-908, 2012
16. Kangas J, Savolainen H: Urinary thiosulphate as an indicator of exposure to hydrogen sulphide vapour. Clin Chim Acta 164: 7-10, 1987
17. Sabry ZI, Shadarevian SB, Cowan JW, Campbell JA: Relationship of dietary intake of sulphur amino-acids to urinary excretion of inorganic sulphate in man. Nature 206: 931-933, 1965
18. Wilson HE: Studies in nitrogen and sulphur metabolism. Biochem J 20: 76-83, 1926
19. Frassetto LA, Lanham-New SA, Macdonald HM, Remer T, Sebastian A, Tucker KL, Tylavsky FA: Standardizing terminology for estimating the diet-dependent net acid load to the metabolic system. J Nutr 137: 1491-1492, 2007
20. Szabó C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935, 2007
21. Yang G,Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, Wang R: H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590, 2008
22. Tokuda K, Kida K, Marutani E, Crimi E, Bougaki M, Khatri A, Kimura H, Ichinose F: Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal 17: 11-21, 2012
23. Levitt MD, Furne J, Springfield J, Suarez F, DeMaster E: Detoxification of hydrogen sulfide andmethanethiol in the cecalmucosa. J Clin Invest 104: 1107-1114, 1999
24. Hayden MR, Goldsmith DJ: Sodium thiosulfate: New hope for the treatment of calciphylaxis. Semin Dial 23: 258-262, 2010
25. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S: Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 74: 1444-1453, 2008
26. Farese S, Stauffer E, Kalicki R, Hildebrandt T, Frey BM, Frey FJ, Uehlinger DE, Pasch A: Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J AmSoc Nephrol 6: 1447-1455, 2011
27. Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR: Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol 294: R1930-R1937, 2008
28. Ratnam S, Maclean KN, Jacobs RL, Brosnan ME, Kraus JP, Brosnan JT: Hormonal regulation of cystathionine beta-synthase expression in liver. J Biol Chem277: 42912-42918, 2002
29. Newman EV, Gilman A, Philips FS: The renal clearance of thiosulfate in man. Bull Johns Hopkins Hosp 79: 229-242, 1946
30. Ullrich KJ, Rumrich G, Klöss S: Bidirectional active transport of thiosulfate in the proximal convolution of the rat kidney. Pflugers Arch 387: 127-132, 1980
31. Foulks J, Brazeau P, Koelle ES, Gilman A: Renal secretion of thiosulfate in the dog. Am J Physiol 168: 77-85, 1952
32. Bucht H: On the tubular excretion of thiosulfate and creatinine under the influence of caronamide. Scand J Clin Lab Invest 1: 270-276, 1949
33. Silve C: Tubular handling and regulation of sulphate. Nephrol Dial Transplant 15[Suppl 6]: 34-35, 2000
34. Morris ME, Murer H: Molecular mechanisms in renal and intestinal sulfate (re)absorption. J Membr Biol 181: 1-9, 2001
35. Durand M, Weinstein P: Thiosulfate in human urine following minor exposure to hydrogen sulfide: Implications for forensic analysis of poisoning. Forensic Toxicol 25: 92-95, 2007
36. Feunekes GI, Van Staveren WA, De Vries JH, Burema J, Hautvast JG: Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr 58: 489-496, 1993
37. van den Berg E, EngberinkMF, Brink EJ, van BaakMA, Gans RO, Navis G, Bakker SJ:Dietary protein, blood pressure and renal function in renal transplant recipients. Br J Nutr 109: 1463-1470, 2013
38. National Institute for Public Health and the Environment: Dutch Food Composition Table of 2006. Available at: http://www.rivm.nl/en/Topics/D/Dutch-Food-Composition-Database/Publications. Accessed December 1, 2013
39. Newton GL, Dorian R, Fahey RC: Analysis of biological thiols: Derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography. Anal Biochem 114: 383-387, 1981
40. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
41. Du Bois D, Du Bois EF: Clinical calorimetry. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17: 863-871, 1916
42. Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AM, van der A DL, Moons KG, Navis G, Bakker SJ, Beulens JW: Prediction models for risk of developing type 2 diabetes: Systematic literature search and independent external validation study. BMJ 345: e5900, 2012
43. Vittinghoff E,McCullochCE: Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165: 710-718, 2007
44. Schisterman EF, Cole SR, Platt RW: Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 20: 488-495, 2009